06/14/2021
7:32 PM | Godlewski Laura Lee (Reporting)
HTG Molecular Diagnostics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2021
7:30 PM | HTG Molecular Diagnostics (Issuer)
Lawson Byron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2021
7:24 PM | HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2021
7:21 PM | HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2021
5:22 AM | HIRSCHMAN ORIN (Filed by)
HTG Molecular Diagnostics (Subject)
| Form SC 13G
| |
04/05/2021
3:09 PM | HTG Molecular Diagnostics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2021
4:49 PM | HTG Molecular Diagnostics (Issuer)
Lawson Byron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2021
4:47 PM | HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2021
4:45 PM | HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2021
4:24 PM | HTG Molecular Diagnostics (Filer)
| Form 424B5
| |
|
02/16/2021
10:37 AM | HTG Molecular Diagnostics (Subject)
LYTTON LAURENCE W (Filed by)
| Form SC 13G/A
| |
02/16/2021
5:23 AM | HTG Molecular Diagnostics (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SC 13G/A
| |
02/12/2021
4:05 PM | HTG Molecular Diagnostics (Subject)
Stonepine Capital Management, LLC (Filed by)
| Form SC 13G/A
| |
02/11/2021
11:58 AM | HTG Molecular Diagnostics (Subject)
Samjo Capital LLC (Filed by)
| Form SC 13G/A
| |
01/19/2021
3:05 PM | HTG Molecular Diagnostics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/15/2021
3:06 PM | HTG Molecular Diagnostics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/06/2021
7:00 AM | HTG Molecular Diagnostics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2021
7:15 AM | HTG Molecular Diagnostics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2021
5:00 PM | HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2021
4:57 PM | HTG Molecular Diagnostics (Issuer)
Lawson Byron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2021
4:55 PM | HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2021
4:53 PM | HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2020
5:14 PM | Godlewski Laura Lee (Reporting)
HTG Molecular Diagnostics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2020
5:13 PM | HTG Molecular Diagnostics (Issuer)
Lawson Byron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2020
5:12 PM | HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2020
5:10 PM | HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2020
5:08 PM | HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2020
3:15 PM | HTG Molecular Diagnostics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/10/2020
3:16 PM | HTG Molecular Diagnostics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/02/2020
4:47 PM | HTG Molecular Diagnostics (Issuer)
Lawson Byron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2020
4:39 PM | HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2020
4:37 PM | HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2020
4:35 PM | HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2020
5:04 PM | Godlewski Laura Lee (Reporting)
HTG Molecular Diagnostics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2020
5:01 PM | HTG Molecular Diagnostics (Issuer)
Lawson Byron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2020
5:00 PM | HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2020
4:59 PM | HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2020
4:54 PM | HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2020
4:38 PM | HTG Molecular Diagnostics (Issuer)
LAFRANCE JAMES T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2020
4:14 PM | HTG Molecular Diagnostics (Issuer)
McCracken Lee R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2020
4:06 PM | HANHAM ANN (Reporting)
HTG Molecular Diagnostics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2020
3:53 PM | GRIFFIN MICHELLE RENEE (Reporting)
HTG Molecular Diagnostics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2020
3:48 PM | George Harry A. (Reporting)
HTG Molecular Diagnostics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2020
4:18 PM | HTG Molecular Diagnostics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/20/2020
3:00 PM | HTG Molecular Diagnostics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2020
3:10 PM | HTG Molecular Diagnostics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/11/2020
3:06 PM | HTG Molecular Diagnostics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2020
11:52 AM | HTG Molecular Diagnostics (Filer)
| Form CT ORDER
| |
07/07/2020
3:15 PM | HTG Molecular Diagnostics (Filer)
| Form DEFA14A
| |
07/07/2020
3:05 PM | HTG Molecular Diagnostics (Filer)
| Form DEF 14A
| |
06/26/2020
4:22 PM | HTG Molecular Diagnostics (Filer)
| Form PRE 14A
| |
06/25/2020
3:45 PM | HTG Molecular Diagnostics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2020
5:21 PM | HTG Molecular Diagnostics (Issuer)
Lawson Byron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
5:19 PM | Godlewski Laura Lee (Reporting)
HTG Molecular Diagnostics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
5:17 PM | HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
5:15 PM | HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
5:13 PM | HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2020
8:11 PM | Blue Water Life Science Master Fund, Ltd. (Filed by)
HTG Molecular Diagnostics (Subject)
| Form SC 13G/A
| |
05/13/2020
3:10 PM | HTG Molecular Diagnostics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2020
5:05 AM | HTG Molecular Diagnostics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2020
4:28 PM | HTG Molecular Diagnostics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/25/2020
11:35 AM | HTG Molecular Diagnostics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2020
8:46 PM | HTG Molecular Diagnostics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2020
8:43 PM | HTG Molecular Diagnostics (Filer)
| Form 424B5
| |
02/26/2020
7:22 AM | HTG Molecular Diagnostics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2020
11:23 AM | HTG Molecular Diagnostics (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SC 13G
| |
02/04/2020
9:35 AM | Cowen Prime Services LLC (Filed by)
HTG Molecular Diagnostics (Subject)
| Form SC 13G
| |
01/31/2020
2:29 PM | HTG Molecular Diagnostics (Subject)
Samjo Capital LLC (Filed by)
| Form SC 13G
| |
01/27/2020
4:26 PM | HTG Molecular Diagnostics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2020
3:40 PM | Godlewski Laura Lee (Reporting)
HTG Molecular Diagnostics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2020
3:38 PM | HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2020
3:37 PM | HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2020
7:05 AM | HTG Molecular Diagnostics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2020
3:53 PM | HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2020
3:52 PM | HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2020
3:50 PM | HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2019
4:42 PM | Godlewski Laura Lee (Reporting)
HTG Molecular Diagnostics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2019
4:36 PM | HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2019
4:32 PM | HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2019
11:15 PM | HTG Molecular Diagnostics (Filer)
| Form EFFECT
| |
11/18/2019
3:15 PM | HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2019
3:07 PM | HTG Molecular Diagnostics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/10/2019
10:35 AM | FMR LLC (Filed by)
HTG Molecular Diagnostics (Subject)
| Form SC 13G/A
| |
10/07/2019
5:03 AM | HTG Molecular Diagnostics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2019
3:29 PM | HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2019
3:27 PM | HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2019
10:05 AM | HTG Molecular Diagnostics (Subject)
Serrado Capital LLC (Filed by)
| Form SC 13G
| |
09/30/2019
7:38 AM | Blue Water Life Science Master Fund, Ltd. (Filed by)
HTG Molecular Diagnostics (Subject)
| Form SC 13G
| |
09/27/2019
5:52 PM | HTG Molecular Diagnostics (Issuer)
LYTTON LAURENCE W (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/23/2019
4:19 PM | HTG Molecular Diagnostics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2019
4:16 PM | HTG Molecular Diagnostics (Filer)
| Form 424B5
| |
09/19/2019
3:05 PM | HTG Molecular Diagnostics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2019
3:02 PM | HTG Molecular Diagnostics (Filer)
| Form 424B5
| |
09/16/2019
3:45 PM | HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2019
3:42 PM | Godlewski Laura Lee (Reporting)
HTG Molecular Diagnostics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2019
3:20 PM | HTG Molecular Diagnostics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2019
4:28 PM | HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2019
4:24 PM | HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2019
4:20 PM | Godlewski Laura Lee (Reporting)
HTG Molecular Diagnostics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2019
3:34 PM | GRIFFIN MICHELLE RENEE (Reporting)
HTG Molecular Diagnostics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
